An Interview with Thomas Widiger
|
|
- Noel Phelps
- 6 years ago
- Views:
Transcription
1 Annual Reviews Conversations Presents An Interview with Thomas Widiger Annual Reviews Audio First published online on March 27, 2012 Annual Reviews Audio interviews are online at Copyright 2012 by Annual Reviews. All rights reserved Host: Anna Rascouët-Paz Anna Rascouët-Paz: Hello, and welcome to Annual Reviews Audio, part of the Conversation Series from Annual Reviews, where insightful research begins. I am your host, Anna Rascouët-Paz. In each episode of our show, we speak to top scientists in fields ranging from astrophysics to sociology. Today, we are talking to Thomas Widiger, professor of psychology at the University of Kentucky and a member of the Editorial Committee of the Annual Review of Clinical Psychology. Professor Widiger was the research coordinator for the fourth edition of the Diagnostic and Statistical Manual of Mental Disorders, also known as DSM-IV. He was also a cochair of the National Institute of Mental Health and the Research Planning Conference for DSM-5 Personality Disorders. Professor Widiger, welcome to our show. Thomas Widiger: Thanks a lot. Really glad to be here and participate in this. Anna Rascouët-Paz: The reason I m calling you today is that you wrote a paper with Allen Frances, who was the chair of the DSM-IV 1
2 task force, in which you both tried to draw lessons from your experience so as to warn those involved in DSM-5 about the potential pitfalls. Thomas Widiger: Yes. Anna Rascouët-Paz: Research coordinator for DSM-IV what exactly does this entail? Thomas Widiger: Well, that job was primarily working with Allen Frances as the chair, as you said, and Harold Pincus, the vice chair. We developed the methods by which DSM-IV was going to be developed. One of the mandates given to us was to have a much more strongly empirically based nomenclature. We set up a procedure for that, a three-stage procedure, involving literature reviews, data analyses and field trials, and, in all cases, emphasizing that authors were not to try to provide the best results, or make the best case for what they re proposing, but to cover all the alternative proposals and major concerns regarding these proposals. I just monitored that, and then all of that came out in the four-volume DSM-IV Sourcebook as a result. Anna Rascouët-Paz: Tell us a bit more about the process and the guidelines. You say in the paper that you adopted a more conservative approach than in earlier editions. How did this translate, practically? Thomas Widiger: It s always been unclear exactly what should be the basis for adding a new diagnosis, for example, or revising a diagnostic criterion set. It certainly was the case in DSM-III and -III-R that it was pretty liberal. Bob Spitzer, in one place, stated what the threshold was, and it was that if a group of clinicians said they see a certain condition, and they could come up with a reliable criteria set, then it would be included in a diagnostic manual. This, however, led to a lot of very controversial proposals, four of which were actually eventually vetoed by the Board of Trustees of the APA [American Psychological Association]: paraphilic rapism, premenstrual dysphoric disorder, sadistic personality disorder, and selfdefeating [personality disorder]. There was a mandate for DSM-IV to have a much more careful and conscientious effort to address possible social consequences, costs of including a new diagnosis, and whether or not the proposal actually had empirical support. It really was a useful process because there was an apparent tendency in DSM-IV that the people who were appointed to the task force and work groups always had a strong invested interest in their ideas and their proposals, and they wanted to get them through. Unless you monitor them closely, there s a tendency to try to downplay opposing research and downplay concerns. Anna Rascouët-Paz: This is what you call in the paper reining in the creativity of the experts, right? Thomas Widiger: That s correct. Anna Rascouët-Paz: Can you give us a few examples of how DSM-IV changed clinical psychiatry and psychology? Specifically, we re talking about the problem of overdiagnosis. You were really careful, probably more careful than in earlier editions, and yet you came upon a few problems that you hadn t necessarily anticipated. Thomas Widiger: It s very difficult to anticipate how a revision to criteria will actually play out 2 Widiger
3 in practice, or how it will impact society and the practice of psychiatry and clinical psychology. Whenever you have something in a DSM, it provides a tremendous sense of credibility in the view of the public and the profession their assumption that Okay, it must be a well-validated condition to have been included. Then we tinker with diagnostic criteria. The wording may have such an effect that the problems may change substantially. We always, in the field trials, compared the 15 criteria sets to the proposals. But the DSM-IV field trials were very limited. There were only 10 of them, and they re confined to only about a similar number of diagnoses. A lot of the ideas that were approved probably weren t field tested as well as they should have been, which resulted in some rather dramatic increases in certain diagnoses. Anna Rascouët-Paz: How does this translate for DSM-5? How do you see this coming for the next edition that s coming out next year? Do you feel that the field trials are happening that there s enough vetting happening for the inclusion of new disorders? Thomas Widiger: Well, it s an interesting process. One thing that is different for DSM-5 than for DSM-IV is the Internet process. That really wasn t as strong of a factor in DSM-IV. In one regard, the vetting of the proposals is more open in DSM-5 than in DSM-IV because they posted them on the Internet, and a lot of people could respond to them. A lot more people were aware of them. DSM-IV it was the old postal mail--delivery system, where there were small minipaperback versions that were freely made available, but you d have to ask for them, so the communication was much slower. On the other hand, we had a much more conservative process for the development of proposals and for the empirical documentation. In DSM-5, for example, they were going to start the field trials without the proposals ever even being posted. They were eventually posted, but they were planning on getting the field trials started before the posting actually was going to occur if that was the original intention to actually post them. Once you start the field trials with the proposals, the train has now left the station, and it s very hard at that point to make any strong major impact on it. I think the process in DSM-5, in some regards even though it is on the Internet and that makes it more open even the existence of that may have been actually prompted by the outside critical reviewers, by the letter by Allen Frances and Bob Spitzer to the Board of Trustees to actually delay the field trials until it was posted. The field trial, itself, is far more limited than was the case in DSM-IV. In DSM-IV all the proposals had to be compared to DSM-III-R criteria sets, and alternative proposals had to be tested, and they had to include validators to determine whether or not the revisions were likely to increase or decrease validity. None of that is being required in DSM-5. The DSM-5 field trials are confined largely to feasibility and interrater reliability, and they re not collecting data on the DSM-IV criteria sets, so you don t really know whether or not a proposal will radically change prevalence whether it improves the validity of the diagnosis or perhaps decreases it. It s a far more limited field trial, more like what was done for DSM-III. Anna Rascouët-Paz: Examining another problem that people have raised concern about: It appears that about 70% of the professionals involved with the making of DSM-5 have ties to the pharmaceutical industry. Is this a concern for you? Thomas Widiger: It s not a concern for me for DSM-5, not at least by what I m aware of. It s my An Interview with Thomas Widiger 3
4 understanding and I don t know this for a fact, but this is my understanding that they initially appointed a number of persons and that a number of them did have some degree of financial connection to a pharmaceutical industry. It s obvious that the pharmaceutical industry would be highly invested in increasing the number of diagnoses and lowering thresholds. But they then implemented a rule that you couldn t get beyond a certain amount of financial connection with a pharmaceutical industry, so these persons had to resign. I don t think there is a strong financial connection with respect to group members decisions in any pharmaceutical industry. Anna Rascouët-Paz: Turning to your focus: You focus on personality disorders, and you wrote a paper for us a couple of years ago where you advocated a new, dimensional system of diagnosis. Would you be able to explain this system to us, and explain to us how it s different from the way that it s done now? Thomas Widiger: Let me also emphasize that Allen Frances and I probably have a different view on this, but both of those views are acknowledged in the paper. I ve long advocated for shifting from the categorical model of diagnosis to a dimensional model that recognizes that personality disorders are maladaptive variants of general personality traits. I work from the perspective of the five-factor model, which is certainly the predominant dimensional model of general personality structure developed in psychology, whereas DSM-IV works from a more traditional clinical perspective where there exist these categorically distinct syndromes that represent some sort of qualitative disease or illness. I would say DSM-5 is clearly shifting toward this five-factor dimensional assessment. The proposal for DSM-5 is to include a five-factor model, five broad domains, that are closely aligned with the five-factor model of general psychology; the disorders themselves would be diagnosed largely by those traits within that model, although the work group also will have some theoretically based, self--other impairments that they feel are impairments that are qualitatively distinct from personality traits. I would disagree with that particular aspect of it. But outside of that, it s a pretty close shift to what I d been proposing in the prior Annual Reviews paper. Allen Frances would say he feels that it s just too radical of a shift to actually make that change for DSM-5. Anna Rascouët-Paz: This is a concern that s also been raised. It s a question of looking at personalities in terms of spectra. You have adaptive traits, and you have maladaptive traits that, essentially, everybody has to a lesser or greater extent. The worry that comes up is that if you re going to use a spectrum system, the threshold for diagnosis is going to be lower, and normality is going to become the exception. How do you respond to that? Thomas Widiger: One doesn t know what will happen unless one does the research. That s where Allen and I would agree. I m not sure they re even collecting any data on this themselves. It s my understanding they re not comparing their current diagnostic system, using these traits, to the DSM-IV criteria sets. They re not going to be able to tell us to what extent this way of diagnosing personality disorders will radically shift the problem rates for each disorder. They don t know what the cutoff points will be. They have seven traits, let s say, for borderline [personality disorder], and they don t know how many you have to have to get the diagnosis. What they re saying on the Web site right now is, You have to have all seven, but it s my understanding that they re just saying that because they have no basis to say anything else. They 4 Widiger
5 won t require all the seven because that would be far too restrictive. But how many would it be three, four, or five? I don t know how they re going to make that decision. I would be sympathetic with the concern that this could have a major dramatic change in the prevalence of personality disorder diagnoses. I would wish that they would be collecting the data to justify whatever threshold they use to have some sort of clinical meaningfulness. Anna Rascouët-Paz: Right. It seems that it would be something difficult to implement for clinicians, people who are practicing psychology and psychiatry with patients directly on a daily basis. That would require some training, right? Thomas Widiger: Well, they won t be as familiar with the trait approach to diagnosis as they are with the diagnostic criteria sets. But I m not as worried about that as some might be because I don t see the trait approaches being that tremendously difficult. The traits are rather obvious in terms of what they are. If you have specific criteria for each trait, then I don t think clinicians will have that much difficulty with it. I do agree that it ll look like quite a different system for them. Again, it would be useful to have some piloting of that. The field trial is doing that. They re having clinicians apply these traits in a number of I think four sites, and they ll have some information about how feasible or how acceptable this approach is to those clinicians. Anna Rascouët-Paz: In terms of new diagnoses or new disorders that will be added to DSM- 5 at least, it s rumored that they will be added to DSM-5, like bereavement, Internet addiction what do you make of these? Thomas Widiger: I think there is a real quality in DSM-5 of having quite a large number of new proposals, much more broadening as to what constitutes a mental disorder. They re getting a lot of negative publicity over this, again in part because of the explosive Internet communication. I also feel that a lot of the criticism probably is deserved. I m concerned that they re not doing a good enough job of anticipating problems and misapplications. For example I mean, they do have an outstanding paper by Ken Kendler and others, including, I think, the chair and vice chair of the task force, which sets forth the empirical support they should have for a new change, and a further statement that each proposal must acknowledge and address possible consequences of a new proposal. But if you actually look at the products that are coming out, the work groups vary tremendous in how well they follow the Kendler outline. If you look at the Web site and anybody can go there themselves, and I certainly encourage people to reach their own judgments they could go to the Web site and look at the review for hypersexual disorder, a brand-new diagnosis involving your life revolving around sex. It would include things like an addiction to porn, or going to strip clubs an excessive amount. The review for that, I think, is outstanding. But if you look at some of the other reviews, there s next to nothing the review for change in the [unintelligible] to substance dependence to behavioral addiction, and you fold then pathological gambling into that. Once you ve done that, you can fold in lots of other things, like Internet addiction and shopping addiction. The review for that doesn t address any of those concerns. It s just two sentences, which say that there s a lot of similarities between substance dependence and pathological gambling. Then you have some number 15, 20 of citations, and that s it. No discussion at all about the potential consequences. The bereavement isn t really a new diagnosis. It s the idea of removing bereavement exclusion criteria. Currently, you don t diagnose somebody with major depression who s depressed because An Interview with Thomas Widiger 5
6 they lost a significant loved one. That s been a tradition in the long history of psychiatry. The proposal to remove it really comes from the compelling logic that what s the difference between the loss of a loved one versus the loss of a job, versus the loss of physical health. All those things are depressing, but if we would diagnose major depressive disorder in response to those losses, why make an exception for the loss of a loved one? I agree with that logic. That s really very compelling logic. But it s quite a fundamental change to suggest to people that if you lost all your children, or you lost your husband or your wife, and it s been now three weeks, and you re still depressed about it, then you re mentally ill. You re mentally ill for being so depressed about having lost somebody. I don t think they appreciate that that could lead to a tremendous amount of overpathologizing what many people think is an appropriate reaction to such a loss. Anna Rascouët-Paz: Right. When you talk to clinicians, how do you describe the DSM? What do you tell them this is? What do you tell them this is not? How should people understand the DSM? Thomas Widiger: Many people can confuse the DSM with something like a periodic table of elements that it s something that out there in nature, and it exists. The DSM is a set of constructs. It s more a set of perceptions and hypotheses. It represents the beliefs of the field regarding what would constitute a mental disorder. In no case has there ever been any laboratory study laboratory instrument I should have said that could document that this thing exists independently of our opinions. That makes it fundamentally very different. I think it s very credible. I think those opinions are largely correct. I think it s correct to think that schizophrenia is a mental disorder, that psychopathy is a mental disorder. But it is an opinion, so I wouldn t want someone to reify what the DSM is, and realize that it could be wrong in some cases. It s open to question and debate. Anna Rascouët-Paz: Thank you very much for your time today. It s been a pleasure talking to you, Professor Widiger. Thomas Widiger: I enjoyed it myself. I m glad you called me. Anna Rascouët-Paz: Thank you very much. You ve been listening to Annual Reviews Audio. For 80 years, Annual Reviews has guided scientists to the essential research literature in the biomedical, life, physical, and social sciences. Learn more at I m Anna Rascouët-Paz. Thanks for listening. [End of audio] Duration: 20 minutes 6 Widiger
UWE Bristol. Patient / carer feedback for Adult Branch Nursing Students in practice
UWE Bristol Patient / carer feedback for Adult Branch Nursing Students in practice Context NMC and Department of Health drivers to involve service users/carers in student assessment process Formalising
More informationWelcome to Progress in Community Health Partnerships latest episode our Beyond the Manuscript podcast. In each
Beyond the Manuscript 91 Podcast Interview Transcript Erin Kobetz, Joan Bloom, Irma Robbins, Kim Engelman Welcome to Progress in Community Health Partnerships latest episode our Beyond the Manuscript podcast.
More informationDeciphering Chronic Pain and Pain Medicine
Deciphering Chronic Pain and Pain Medicine Deciphering Chronic Pain and Pain Medicine Hello and welcome to Primary Care Today on ReachMD. I m your host, Dr. Brian McDonough, and I m very happy to have
More informationYou re listening to an audio module from BMJ Learning. Hallo. I'm Anna Sayburn, Senior Editor with the BMJ Group s Consumer Health Team.
Transcript of learning module Shared decision making (Dur: 26' 13") Contributors: Anna Sayburn and Alf Collins Available online at: http://learning.bmj.com/ V/O: You re listening to an audio module from
More informationUNDERSTANDING CAPACITY & DECISION-MAKING VIDEO TRANSCRIPT
I m Paul Bourque, President and CEO of the Investment Funds Institute of Canada. IFIC is preparing materials to assist advisors and firms in managing effective and productive relationships with their aging
More informationBehaviorism: An essential survival tool for practitioners in autism
Behaviorism: An essential survival tool for practitioners in autism What we re going to do today 1. Review the role of radical behaviorism (RB) James M. Johnston, Ph.D., BCBA-D National Autism Conference
More informationDr. Coakley, so virtual colonoscopy, what is it? Is it a CT exam exactly?
Virtual Colonoscopy Webcast January 26, 2009 Fergus Coakley, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of UCSF Medical Center, its medical staff or Patient
More informationSelf Esteem and Purchasing Behavior Part Two.
Self Esteem and Purchasing Behavior Part Two www.howtodoubleyourbusiness.com G: Hi Sharon, honey. S: Hi, honey. G: Well, I want everybody to know that Sharon and I just did a terrific recording and went
More informationAn Update on BioMarin Clinical Research and Studies in the PKU Community
An Update on BioMarin Clinical Research and Studies in the PKU Community Barbara Burton, MD, Professor of Pediatrics, Northwestern University Feinberg School of Medicine, Director of PKU Clinic, Children
More informationGenetic Counselor: Hi Lisa. Hi Steve. Thanks for coming in today. The BART results came back and they are positive.
Hi, I m Kaylene Ready, a genetic counselor who specializes in the education and counseling of individuals at high-risk for hereditary breast and ovarian cancer syndrome. Women with an inherited BRCA 1
More informationFrom Individual to Community: Changing the Culture of Practice in Children s Mental Health
From Individual to Community: Changing the Culture of Practice in Children s Mental Health An interview with Ron Manderscheid, a national leader on mental health and substance abuse and member of FrameWorks
More informationHello and welcome to Patient Power sponsored by UCSF Medical Center. I m Andrew Schorr.
The Integrated Approach to Treating Cancer Symptoms Webcast March 1, 2012 Michael Rabow, M.D. Please remember the opinions expressed on Patient Power are not necessarily the views of UCSF Medical Center,
More informationQUESTIONS ANSWERED BY
Module 16 QUESTIONS ANSWERED BY BERNIE SIEGEL, MD 2 Q How do our thoughts and beliefs affect the health of our bodies? A You can t separate thoughts and beliefs from your body. What you think and what
More informationTHRIVING ON CHALLENGE NEGATIVE VS. POSITIVE AUTHENTICITY & ABUNDANCE ONLINE COACHING
THRIVING ON CHALLENGE NEGATIVE VS. POSITIVE AUTHENTICITY & ABUNDANCE ONLINE COACHING Positive Psychology $11.50 US What the scientific study of happiness has to offer the coaching world, and vice versa
More informationDisclosing medical errors to patients: Recent developments and future directions
it is exciting to see all of you here because when I look back on my time in g y y medical education and look at practice now, I think this area of how we communicate with patients when something is going
More informationand areas of cannabis research that require further study:
The CCIC Podcast March 25, 2015 This month: Prof. Raphael Mechoulam Interview by Dr. Mark A. Ware www.ccic.net/podcast Introduction Hello and welcome to the CCIC Podcast. The CCIC Podcast is a series of
More informationRecording Transcript Wendy Down Shift #9 Practice Time August 2018
Recording Transcript Wendy Down Shift #9 Practice Time August 2018 Hi there. This is Wendy Down and this recording is Shift #9 in our 6 month coaching program. [Excuse that I referred to this in the recording
More informationStep Five. Admitted to ourselves and another human being the exact nature of our wrongs.
Step Five Admitted to ourselves and another human being the exact nature of our wrongs. Our Basic Text tells us that Step Five is not simply a reading of Step Four. Yet we know that reading our Fourth
More informationPerioperative Stroke for the General Anesthesiologist and Specialist
Perioperative Stroke for the General Anesthesiologist and Specialist 2017 {Music} Dr. Alan Jay Schwartz: Hello. This is Alan Jay Schwartz, Editor-in-Chief of the American Society of Anesthesiologists 2017
More informationPCSK9 Antibodies for Dyslipidemia: Efficacy, Safety, and Non-Lipid Effects
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/lipid-luminations/pcsk9-antibodies-dyslipidemia-efficacy-safety-and-nonlipid-effects/8335/
More informationSection 4 Decision-making
Decision-making : Decision-making Summary Conversations about treatments Participants were asked to describe the conversation that they had with the clinician about treatment at diagnosis. The most common
More informationThis is an edited transcript of a telephone interview recorded in March 2010.
Sound Advice This is an edited transcript of a telephone interview recorded in March 2010. Dr. Patricia Manning-Courtney is a developmental pediatrician and is director of the Kelly O Leary Center for
More informationCOMMENTS ON THE PAPER OF PROF. PARTHA DASGUPTA
21_Stiglitz_A_G.qxd:Layout 1 16-10-2008 12:07 Pagina 563 COMMENTS ON THE PAPER OF PROF. PARTHA DASGUPTA I thought Prof. Dasgupta s paper was extremely interesting and I think it raised a number of points.
More informationLiving My Best Life. Today, after more than 30 years of struggling just to survive, Lynn is in a very different space.
Living My Best Life Lynn Allen-Johnson s world turned upside down when she was 16. That s when her father and best friend died of Hodgkin s disease leaving behind her mom and six kids. Lynn s family was
More informationBeattie Learning Disabilities Continued Part 2 - Transcript
Beattie Learning Disabilities Continued Part 2 - Transcript In class Tuesday we introduced learning disabilities and looked at a couple of different activities that are consistent and representative of
More informationPneumococcal Vaccines: Questions and Answers
Pneumococcal Vaccines: Questions and s Question 1 What is pneumococcal disease? What is pneumococcal disease? So pneumococcal disease is a group of diseases that are caused by a bacteria. Most of us are
More informationLiving well with dementia: Plan
Living well with dementia: Recognizing and Addressing the Impact of Stigma Plan Draw on data from a recent study to: Recognize stigma as an important issue in living well with dementia Explore the implications
More information"PCOS Weight Loss and Exercise...
"PCOS Weight Loss and Exercise... By Dr. Beverly Yates Dr. of Naturopathic Medicine, PCOS Weight Loss Expert & Best Selling Author Table of Contents Introduction... 2 If You Are Dieting Do You Need To
More informationNOT ALONE. Coping With a Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD)
NOT ALONE Coping With a Diagnosis of Facioscapulohumeral Muscular Dystrophy (FSHD) FOR THE NEWLY DIAGNOSED AND THEIR LOVED ONES, FROM THOSE WHO HAVE TRAVELED THIS ROAD BEFORE YOU We re not alone. We re
More informationBiomarkers for Underreported Alcohol Use
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/biomarkers-for-underreported-alcohol-use/3891/
More informationWHEN OBAMA BECAME PRESIDENT: MEANINGS OF AGING IN A TIME OF PARADIGM SHIFTS
WHEN OBAMA BECAME PRESIDENT: MEANINGS OF AGING IN A TIME OF PARADIGM SHIFTS Jacquelyn Browne Ph.D., LCSW Principal Investigator Yulia Watters Ph.D., LMFT Co Principal Investigator OBJECTIVES OF THE STUDY
More informationReduce Tension by Making the Desired Choice Easier
Daniel Kahneman Talk at Social and Behavioral Sciences Meeting at OEOB Reduce Tension by Making the Desired Choice Easier Here is one of the best theoretical ideas that psychology has to offer developed
More informationRichard Taylor. Ph.D., is the author of Alzheimer s from the Inside Out.
PERSPECTIVES 60 Richard Taylor Ph.D., is the author of Alzheimer s from the Inside Out. My name is Richard Taylor. I live in Houston, Texas, and for the past few years I have been living with the symptoms
More informationCarrier Screening in your Practice Is it Time to Expand your View?
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-industry-feature/carrier-screening-your-practice-it-time-expandyour-view/9648/
More informationSection 4 - Dealing with Anxious Thinking
Section 4 - Dealing with Anxious Thinking How do we challenge our unhelpful thoughts? Anxiety may decrease if we closely examine how realistic and true our unhelpful/negative thoughts are. We may find
More informationNervous System Case Study
MODULE 14: ANATOMY & PHYSIOLOGY CASE STUDY #4 Nervous System Case Study Professor Daniels Case: Misplaced Memories OVERVIEW: Professor Daniels is experiencing some troubling changes in his personality
More informationQuestions for Eric London: Alternative diagnoses for autism
OPINION, Q&A Questions for Eric London: Alternative diagnoses for autism BY JESSICA WRIGHT 2 JANUARY 2015 1 / 7 Deep dive: Listing detailed symptoms rather than assigning a single diagnostic label may
More informationTreating Lung Cancer: Past, Present, & Future Dr. Ramiswamy Govindan Washington University November, 2009
Treating Lung Cancer: Past, Present, & Future Dr. Ramiswamy Govindan Washington University November, 2009 GRACE, the Global Resource for Advancing Cancer Education, is pleased to provide the following
More informationLetter to the teachers
Letter to the teachers Hello my name is Sasha Jacombs I m 12 years old and I have had Type 1 Diabetes since I was four years old. Some of the people reading this may not know what that is, so I had better
More informationDraft 0-25 special educational needs (SEN) Code of Practice: young disabled people s views
Draft 0-25 special educational needs (SEN) Code of Practice: young disabled people s views Young people s consultation When I used to on have the my reviews at school they never used to tell me what was
More informationThe Parent's Perspectives on Autism Spectrum Disorder
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/autism-spectrum/the-parents-perspectives-on-autism-spectrumdisorder/6809/
More informationFINDING THE RIGHT WORDS IN ADVANCED AND METASTATIC BREAST CANCER (ABC/MBC)
FINDING THE RIGHT WORDS IN ADVANCED AND METASTATIC BREAST CANCER (ABC/MBC) Real people. Real communication. Making a real difference. 000989_NOV19_Breast_Cancer_Language_Guide_HCPs_V4_CL.indd 1 What do
More informationEXPERT INTERVIEW Diabetes Distress:
EXPERT INTERVIEW Diabetes Distress: A real and normal part of diabetes Elizabeth Snouffer with Lawrence Fisher Living successfully with type 1 or type 2 diabetes requires the very large task of managing
More informationAn Interview with a Chiropractor
An Interview with a Chiropractor Doctor Scott Warner took the time out of his busy schedule to talk to us about chiropractic medicine what it is, what it isn t, and why he chose it as a profession. What
More informationStudy on Gender in Physics
Listening Practice Study on Gender in Physics AUDIO - open this URL to listen to the audio: https://goo.gl/7xmlgh Questions 1-10 Choose the correct letter, A, B C. Study on Gender in Physics 1 The students
More informationCarotid Ultrasound Scans for Assessing Cardiovascular Risk
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/lipid-luminations/carotid-ultrasound-scans-for-assessing-cardiovascularrisk/4004/
More informationHealthy Communities Conference Ana Diez Roux 1. Okay, good afternoon. It s a pleasure to be here. I guess by, I
1 Okay, good afternoon. It s a pleasure to be here. I guess by, I don t know, things happen in life. I ve become an academic somehow, although I started out as a pediatrician a long time ago. And it s
More informationExpert Tips for Diagnosis and Management of Bacterial Vaginosis
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/miscellaneous/whats-new-bacterial-vaginosis/expert-tips-for-diagnosismanagement-of-bacterial-vaginosis/9894/
More informationComparing Liquid-Based Cytology Methods in the Detection of Cervical Cancer: Perspectives from Dr. Daniel Ferrante
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/advances-in-womens-health/comparing-liquid-based-cytology-methodsdetection-cervical-cancer-perspectives-dr-daniel-ferrante/7592/
More informationHow to Work with the Patterns That Sustain Depression
How to Work with the Patterns That Sustain Depression Module 5.2 - Transcript - pg. 1 How to Work with the Patterns That Sustain Depression How the Grieving Mind Fights Depression with Marsha Linehan,
More informationThe Expanding Value of Biomarkers in NSCLC Treatment
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/closing-gaps-nsclc/the-expanding-value-of-biomarkers-in-nsclctreatment/10283/
More informationJuly Introduction
Case Plan Goals: The Bridge Between Discovering Diminished Caregiver Protective Capacities and Measuring Enhancement of Caregiver Protective Capacities Introduction July 2010 The Adoption and Safe Families
More informationWhat s the Latest in Prostate Cancer Immunotherapy Options?
What s the Latest in Prostate Cancer Immunotherapy Options? Jeri Kim, MD Associate Professor, Department of Geritourinary Medical Oncology The University of Texas MD Anderson Cancer Center Sumit K. Subudhi,
More informationUnraveling Recent Cervical Cancer Screening Updates and the Impact on Your Practice
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationIron Deficiency Anemia in Patients with Inflammatory Bowel Disease ReachMD Page 1 of 7
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationCardiovascular Controversies: Exploring the ACC and AHA Guidelines on the Treatment of Blood Cholesterol
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationSickle Cell Disease: How Should YOU Reassess Management & Treatment?
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/changing-conversation-sickle-cell-disease/sickle-cell-disease-howshould-you-reassess-management-treatment/10184/
More information19 INSTRUCTOR GUIDELINES
STAGE: Recent Quitter You are a pharmacist in a smoking cessation clinic and you receive a phone call from one of your patients, Ms. Onitay. She is moderately panicked and tells you that she has a swollen
More informationMRC talks podcast: Career inspirations: Daniel Freeman, clinical psychologist January 2019
Presenter: Welcome to the MRC talks podcast. I m Isabel Harding. For 2019 we re launching a 12-part career inspirations series. We ll feature 12 scientists, all working in different areas of medical research,
More informationTHE SOCIALABILITY QUESTIONAIRE: AN INDEX OF SKILL
JONATHAN BERENT, A.C.S.W. & ASSOCIATES 17 Maple Drive Great Neck, New York 11021 800-248-2034 THE SOCIALABILITY QUESTIONAIRE: AN INDEX OF SKILL In working with the Socially Challenged, we found a need
More informationNoshima: Any suggestions for making the HIV update better?
Realizing some members on the call were not able to attend the last CAB meeting, Noshima started things off by introducing herself and the other UNC members who will now be assisting with the CAB. After
More informationHow To Treat Resistant Bipolar Patients
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/how-to-treat-resistant-bipolar-patients/3560/
More informationBuilding Friendships: Avoid Discounting
Module 3 Part 2 Building Friendships: Avoid Discounting Objectives: 1. Explore the relationship between stress and discounting. 2. Understand what discounting is and how it relates to stress in relationships.
More informationAspirin Resistance and Its Implications in Clinical Practice
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/aspirin-resistance-and-its-implications-in-clinicalpractice/3819/
More informationWhy Tobacco Cessation?
Tobacco Cessation in Community Settings Introduction Hello and welcome to the Learning and Action Network event, Reaching Those in Need of Tobacco Cessation in Community Settings: Research, Recommendations
More information9 INSTRUCTOR GUIDELINES
STAGE: Ready to Quit You are a clinician in a family practice group and are seeing 16-yearold Nicole Green, one of your existing patients. She has asthma and has come to the office today for her yearly
More informationHelping Families/Caregivers Make the Difficult Decisions for Those Without Capacity
B L I F E O D E A T H T H B I R T H C S Helping Families/Caregivers Make the Difficult Decisions for Those Without Capacity Viki Kind, MA viki@kindethics.com KindEthics.com 805-807-4474 Case Studies Maria:
More informationSTART AUDIO. You re listening to an audio module from BMJ Learning.
BMJ LEARNING PODCAST TRANSCRIPT File: FINAL medically unexplained symptoms.mp3 Duration: 0:16:13 Date: 20/02/2014 Typist: TC6 START AUDIO Recording: You re listening to an audio module from BMJ Learning.
More informationPlease Understand Me, Managing ADHD within a Marriage, this is Stay Happily Married episode number 222.
Announcer: Please Understand Me, Managing ADHD within a Marriage, this is Stay Happily Married episode number 222. Welcome to Stay Happily Married, your source for weekly updates on the latest tips and
More informationWelcome to Progress in Community Health Partnerships latest episode of our Beyond the Manuscript podcast. In
Beyond the Manuscript 45 Podcast Interview Transcript Larkin Strong, Zeno Franco, Mark Flower Welcome to Progress in Community Health Partnerships latest episode of our Beyond the Manuscript podcast. In
More informationUnseen and unheard: women s experience of miscarriage many years after the event
Unseen and unheard: women s experience of miscarriage many years after the event The Forbidden in Counselling and Psychotherapy Keele Conference 2012 Lois de Cruz The wide mouth frog effect Aim Of my PhD
More informationWho Exactly Is This Book For?
This is a chapter excerpt from Guilford Publications. Getting the Best for Your Child with Autism: An Expert's Guide to Treatment by Bryna Siegel. Copyright 2008 Introduction This is a book for parents
More informationShift in Doctor Patient Relationship- Supplement to 2013 North American Education Program
Shift in Doctor Patient Relationship- Supplement to 2013 North American Education Program Marie Namey: I think now because the decision making process is more complex, because there are more medications
More informationBoundaries - What is Appropriate?
Boundaries - What is Appropriate? by Rick Reynolds Much is written on the topic of boundaries so I ve never weighed in on the topic. But after a discussion in the 911 Marriage question and answer session
More informationWhat is Down syndrome?
FREQUENTLY ASKED QUESTIONS PRIMARY What is Down syndrome? People have Down syndrome because they have an extra chromosome. Our bodies are made up of millions and millions of cells and each cell usually
More informationDOCTOR: The last time I saw you and your 6-year old son Julio was about 2 months ago?
DOCTOR: The last time I saw you and your 6-year old son Julio was about 2 months ago? MOTHER: Um, ya, I think that was our first time here. DOCTOR: Do you remember if you got an Asthma Action Plan? MOTHER:
More informationCHIROPRACTIC ADJUSTMENTS TRIGGER STROKE
CHIROPRACTIC I m sending this out for your information!!!! I can see his points on a lot of the issues. I was taught by an AWESOME Chiropractor that an adjustment bruises tissue and that it usually took
More informationDecision-making about implantation of cardioverter defibrillators (ICDs) and deactivation during end of life care
Decision-making about implantation of cardioverter defibrillators (ICDs) and deactivation during end of life care Richard Thomson Professor of Epidemiology and Public Health Institute of Health and Society
More informationClient Care Counseling Critique Assignment Osteoporosis
Client Care Counseling Critique Assignment Osteoporosis 1. Describe the counselling approach or aspects of different approaches used by the counsellor. Would a different approach have been more appropriate
More information3:54 into mp3 file %20Dr.%20Detterbeck_254205_5_v1.mp3
Welcome to Yale Cancer Answers with your hosts doctors Anees, and Steven Gore. Dr. is Associate Professor of Surgical Oncology and Dr. Gore is Director of Hematological Malignancies at Smilow and an expert
More information(WG Whitfield Growden, MD; DR Diane Redington, CRNP)
2795 Estates Drive Park City, UT 84060 TRANSCRIPT FOR VIDEO #6: HOW TO FIND A CLINICAL TRIAL WITH DR. WHITFIELD GROWDEN Interview, Massachusetts General Hospital January 5, 2017 Produced by (WG Whitfield
More informationInvestigating Plinabulin for Prevention of Chemotherapy-Induced Neutropenia
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/project-oncology/origins-and-impacts-severe-neutropenia-newpharmacotherapy/9650/
More informationLet me introduce you to her. That s Barbara Scribner who joins us from Kent, Washington. Barbara, thank you so much for joining us.
Lung Cancer: Detection and Early Intervention Webcast November 30, 2009 Douglas E. Wood, M.D. Jason Chien, M.D., M.S. Barbara Scribner Please remember the opinions expressed on Patient Power are not necessarily
More informationPractices for Demonstrating Empathy in the Workplace
Practices for Demonstrating Empathy in the Workplace These practices have been developed to help leaders at all levels to develop and demonstrate empathy. These practices, when employed in combination,
More informationUnderstanding Thyroid Cancer
Understanding Thyroid Cancer Recorded on: July 25, 2012 Christine Landry, M.D. Surgical Oncologist Banner MD Anderson Cancer Center Please remember the opinions expressed on Patient Power are not necessarily
More informationKids Booklet 5 & on Autism. Create an autism awareness ribbon! Tips for parents & teachers. Activities puzzles
Kids Booklet on Autism Create an autism awareness ribbon! Tips for parents & teachers 5 & Activities puzzles Take a look at what s inside! Questions and Answers About Autism page 2 Brothers and Sisters
More informationLatest Methods to Early Detection for Alzheimer's: Cognitive Assessments and Diagnostic Tools in Practice
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/alzheimers-disease-towards-earlier-detection/latest-methods-earlydetection-alzheimers-cognitive-assessments-and-diagnostic-tools-practice/8321/
More informationUnit 3: EXPLORING YOUR LIMITING BELIEFS
Unit 3: EXPLORING YOUR LIMITING BELIEFS Beliefs and Emotions Bring to mind a negative belief you hold about money. Perhaps it is I don t believe I can win with money or Money is hard to come by. While
More informationVery Short Notes. Short Notes. 1 placebo definition 2 placebo effect definition
Chapter 5 The Placebo Effect Notes and Transcript When you make a speech or presentation, you want to know the material very well, even if you have notes and a transcript to look at. You can learn the
More informationLung Cancer Awareness Month Update 2008
Lung Cancer Awareness Month Update 2008 Guest Expert: Frank, MD Professor of Thoracic Surgery Lynn, MD Professor of Pulmonary Medicine www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center
More informationNONPROFIT CONFLICT COMMUNICATION SKILLS
NONPROFIT CONFLICT COMMUNICATION SKILLS Elise M. Chambers, Esq. Program Director elise@crcminnesota.org 612-813-3206 TODAY, WE LL Get a crash course: Earn a PhD in Conflict Resolution Theory in 10 minutes
More informationProblem Situation Form for Parents
Problem Situation Form for Parents Please complete a form for each situation you notice causes your child social anxiety. 1. WHAT WAS THE SITUATION? Please describe what happened. Provide enough information
More informationThe HPV Data Is In What Do the Newest Updates in Screening Mean For Your Patients?
Transcript Details This is a transcript of a continuing medical education (CME) activity accessible on the ReachMD network. Additional media formats for the activity and full activity details (including
More informationPE Enlargement Bible Reviews
PE Enlargement Bible Reviews I Used Penis Enlargement Bible For 9 Weeks, What Do You Think Of My Results? If you ve tried other penis enlargement products before, and been disappointed, you may have given
More informationGlobal Perspectives on Organ Donation
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/focus-on-global-medicine/global-perspectives-on-organ-donation/3990/
More informationHow to Help Your Patients Overcome Anxiety with Mindfulness
How to Help Your Patients Overcome Anxiety with Mindfulness Video 5 - Transcript - pg. 1 How to Help Your Patients Overcome Anxiety with Mindfulness How to Work with the Roots of Anxiety with Ron Siegel,
More informationMaking Connections: Early Detection Hearing and Intervention through the Medical Home Model Podcast Series
Making Connections: Early Detection Hearing and Intervention through the Medical Home Model Podcast Series Podcast 2 Utilization of the Teach-Back Methodology in Early Hearing Detection and Intervention
More informationSuggested topics to review with your students
Working with Students: Building Blocks for Motivational Interviewing and Brief Intervention Strategies Jason R. Kilmer, Ph.D. University of Washington Associate Professor Psychiatry & Behavioral Sciences
More informationLiving with Diabetes Living with diabetes
Living with Diabetes Living with diabetes Professor David Mathhews Before the turn of the last century, Type 1 diabetes where you ran out of insulin altogether would be entirely fatal. And the first real
More informationWhat is the Economic Impact of Autism Spectrum Disorder?
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/autism-spectrum/what-is-economic-impact-autism-spectrumdisorder/10263/
More information